Wanchen Group(300972)

Search documents
万辰集团: 关于召开公司2025年第三次临时股东会的通知
Zheng Quan Zhi Xing· 2025-09-02 16:15
Meeting Information - The company will hold its third extraordinary general meeting of shareholders on September 18, 2025, starting at 14:30 [1] - Shareholders can participate through on-site voting or online voting via the Shenzhen Stock Exchange systems [1][5] Eligibility and Attendance - All shareholders registered with voting rights as of the close of trading on the day before the meeting are entitled to attend [2] - The meeting will also include company directors, supervisors, senior management, and other required personnel [2] Voting Procedures - Shareholders can vote through on-site attendance, the Shenzhen Stock Exchange trading system, or the internet voting system [1][5] - Only one voting method can be selected for each voting right, and duplicate votes will be counted based on the first submission [1][6] Agenda Items - The agenda items have been approved by the company's board and supervisory committee [4] - The results of the voting for minority investors will be counted separately and disclosed in the meeting resolution announcement [4] Registration Requirements - Corporate shareholders must provide specific documentation for registration, including a business license copy and identification of the legal representative [3][5] - Individual shareholders must present their identification and shareholder account card for registration [5] Network Voting Details - The company provides a platform for online voting, with specific procedures outlined for participation [6] - Voting can occur during designated times, and identity verification is required for online participation [6]
万辰集团: 中审众环会计师事务所关于福建万辰生物科技集团股份有限公司前次募集资金使用情况的鉴证报告
Zheng Quan Zhi Xing· 2025-09-02 16:14
Core Viewpoint - The report details the usage of previously raised funds by Fujian Wancheng Biotechnology Group Co., Ltd., highlighting the financial management and adjustments made to investment projects to enhance operational efficiency and market competitiveness [2][12][14]. Fundraising Overview - The company raised a net amount of RMB 228.60 million from its initial public offering (IPO) after deducting issuance costs [2]. - In a subsequent issuance to specific investors, the company raised RMB 200 million, with a net amount of RMB 193.60 million after expenses [3]. Fund Usage and Management - As of June 30, 2025, the company had utilized RMB 162.59 million from the IPO funds and RMB 142.49 million from the specific issuance funds [4][5]. - The company established special accounts for managing the raised funds, ensuring compliance with regulatory requirements and protecting investor interests [9][10]. Project Adjustments - The company changed the investment project from "Annual Production of 21,000 Tons of Shimeji Mushroom" to "Annual Production of 53,000 Tons of Enoki Mushroom," aiming to improve market competitiveness and reduce production costs [12][14]. - The adjusted investment amount for the new project is RMB 100 million, with a total planned investment of RMB 470.57 million [14]. Financial Performance - As of June 30, 2025, the project for producing 53,000 tons of Enoki mushrooms reported a cumulative loss of RMB 51.39 million, indicating challenges in the edible mushroom business due to market conditions [16].
万辰集团:提名杨帆女士为独立董事候选人
Zheng Quan Ri Bao· 2025-09-02 13:40
Core Viewpoint - Wanchen Group announced the nomination of Ms. Yang Fan as a candidate for the independent director of the company's fourth board of directors [2] Group 1 - The announcement was made on the evening of September 2 [2] - The nomination reflects the company's ongoing efforts to enhance its governance structure [2]
万辰集团:第四届监事会第三十三次会议决议公告
Zheng Quan Ri Bao· 2025-09-02 13:20
证券日报网讯 9月2日晚间,万辰集团发布公告称,公司第四届监事会第三十三次会议审议通过了《关 于公司前次募集资金使用情况报告的议案》《关于制定的议案》。 (文章来源:证券日报) ...
万辰集团:第四届董事会第三十三次会议决议公告
Zheng Quan Ri Bao· 2025-09-02 13:20
Group 1 - The core point of the article is that Wancheng Group announced the approval of multiple proposals, including the nomination of independent director candidates, during the 33rd meeting of its fourth board of directors [2]
万辰集团:9月18日将召开2025年第三次临时股东会
Zheng Quan Ri Bao Wang· 2025-09-02 13:16
Group 1 - The core point of the article is that Wancheng Group (300972) announced it will hold its third extraordinary general meeting of shareholders on September 18, 2025 [1] - The meeting will review multiple proposals, including the nomination of independent director candidates [1]
万辰集团:9月2日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-09-02 11:14
Group 1 - The core viewpoint of the article is that Wancheng Group held its 33rd meeting of the fourth board of directors on September 2, 2025, to discuss internal governance system proposals [1] - For the first half of 2025, Wancheng Group's revenue composition was 98.95% from snack retail and 1.05% from agricultural planting [1] - As of the report date, Wancheng Group's market capitalization was 37.4 billion yuan [1]
万辰集团(300972) - 利益冲突管理制度(草案)
2025-09-02 10:31
福建万辰生物科技集团股份有限公司 利益冲突管理制度(草案) (H 股发行并上市后适用) 第一章 总则 第一条 为切实防范福建万辰生物科技集团股份有限公司(连同其下属子公司, 统称"公司"或"本公司")董事、高级管理人员与公司之间的利益冲突,促进公 司业务的规范发展,根据《福建万辰生物科技集团股份有限公司章程》(以下简称 "《公司章程》")《深圳证券交易所股票上市规则》及《香港联合交易所有限公 司证券上市规则》等有关规定制定本制度。 第二章 适用范围及定义 第二条 本制度适用于公司及下属子公司的董事、高级管理人员。 第三条 本制度所称利益冲突指当公司董事、高级管理人员在履行公司职务所代 表的公司利益与其自身的利益之间存在冲突,可能损害公司和其股东权利的情形。 第三章 利益冲突常见情形 与公司竞争方之间存在聘任关系或活动: (一)在受聘于公司期间,董事、高级管理人员销售任何对公司现有或潜在商 业活动构成竞争的产品,或提供任何对公司现有或潜在商业活动构成竞争的服务。 (二)同时受聘于公司的竞争方,或与公司的竞争方发生任何方式的关联(连) (包括咨询或其他类似身份从事的活动),而损害公司利益的活动,包括但不限于 成为 ...
万辰集团(300972) - 可持续发展(ESG)管理制度
2025-09-02 10:31
第一章 总则 第一条 为进一步加强福建万辰生物科技集团股份有限公司(以下简称"公司") 可持续发展管理,积极履行可持续发展职责,根据《中华人民共和国公司法》《中 华人民共和国证券法》《上市公司治理准则》《企业内部控制基本规范》《深圳证 券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《深圳证券 交易所上市公司自律监管指引第 17 号——可持续发展报告(试行)》等法律法规、 规章和规范性文件以及《福建万辰生物科技集团股份有限公司章程》(以下简称 "《公司章程》")的规定,结合公司的实际情况,制定本制度。 第二条 本制度所称的可持续发展职责,是指公司在经营发展过程中应当履行的 环境(Environmental)、社会(Social)和治理(Governance)方面的责任和义务, 主要包括对自然环境和资源的保护、社会责任的承担以及公司治理的健全、合规和 透明。 福建万辰生物科技集团股份有限公司 可持续发展(ESG)管理制度 第三条 公司开展可持续发展管理工作,是有效履行公司社会责任的需要,有助 于公司及时识别把握风险和机遇,提升公司的可持续发展能力、综合价值。 第四条 本制度所称利益相关方,是指 ...
万辰集团(300972) - 对外捐赠管理制度
2025-09-02 10:31
福建万辰生物科技集团股份有限公司 对外捐赠管理制度 第一章 总则 第一条 为进一步规范公司对外捐赠行为,加强公司对外捐赠事项的管理,更 好地履行公司的社会责任,维护公司股东、债权人及员工利益,根据《中华人民共 和国公益事业捐赠法》《中华人民共和国慈善法》《中华人民共和国公司法》等法 律、法规及《福建万辰生物科技集团股份有限公司章程》,特制定本制度。 第二章 对外捐赠的定义 第二条 本制度所称"对外捐赠",是指公司自愿无偿将其有权处分的合法财 产赠送给合法的受赠人,用于与生产经营活动没有直接关系的公益事业的行为。 第四章 对外捐赠的范围 第八条 公司可以用于对外捐赠的财产包括现金、实物资产等。公司生产经营 需用的主要固定资产、无形资产、持有的股权和债权、国家特准储备物资、国家财 政拨款、受托代管财产、已设置担保物权的财产、权属关系不清的财产,或者变质、 残损、过期报废的商品物资,不得用于对外捐赠。 第五章 对外捐赠的类型和受益人 第三条 本制度适用于公司及下属全资子公司、控股子公司。 第三章 对外捐赠的原则 第四条 公司对外捐赠后,不得要求受赠方在融资、市场准入、行政许可、占 有其他资源等方面创造便利条件,不得 ...